---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-138953"
form_type: "8-K"
ticker: "MDGL"
cik: "0001157601"
company_name: "MADRIGAL PHARMACEUTICALS, INC."
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T08:12:42.361775+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Madrigal ups ATM equity facility by $200M to raise additional capital via Cowen

## Summary
- Amendment to Sales Agreement with Cowen increases ATM capacity by $200M.
- Shares sold through 'at-the-market' offerings under existing shelf registration.
- Company has no obligation to sell; Cowen acts as agent on commercially reasonable efforts.
- Prospectus supplement filed May 9, 2023 for the additional $200M of common stock.

## SEC filing metadata
- accession: 0001193125-23-138953
- form_type: 8-K
- ticker: MDGL
- cik: 0001157601
- company_name: MADRIGAL PHARMACEUTICALS, INC.
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157601/000119312523138953/0001193125-23-138953-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157601/000119312523138953/d416547d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-138953
- JSON: https://secwatch.observer/filing/0001193125-23-138953.json
- Plain text: https://secwatch.observer/filing/0001193125-23-138953.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.